about
Applications of nanotechnology in dermatologyNanocarriers Usage for Drug Delivery in Cancer TherapyCurcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerTetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapyThe Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer TherapyTherapeutic efficacy of nanomedicines for prostate cancer: An updateBreast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Nanocarriers for diagnosis and targeting of breast cancerSilk fibroin-based nanoparticles for drug deliveryNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewEnabling anticancer therapeutics by nanoparticle carriers: the delivery of PaclitaxelNanomedicine therapeutic approaches to overcome cancer drug resistanceCancer nanotechnology: emerging role of gold nanoconjugatesThe Internal Dynamics of Fibrinogen and Its Implications for Coagulation and AdsorptionLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaGlioblastoma Stem-Like Cells: Characteristics, Microenvironment, and TherapyPolymeric nanoparticles for targeted treatment in oncology: current insightsZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coliEdible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer TherapySimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyToxicology and drug delivery by cucurbit[n]uril type molecular containersPeptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal modelsCellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticlesEvaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platformCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorEnhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsEnhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell linesHuman Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38Drug-targeting methodologies with applications: A reviewCharacterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccineEffects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitroImproving ovarian cancer imaging with LHRH-NBs: an experimental studyCurrent applications and future prospects of nanomaterials in tumor therapyLuminescent difluoroboron β-diketonate PEG-PLA oxygen nanosensors for tumor imaging.Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.Selective intracellular vaporisation of antibody-conjugated phase-change nano-droplets in vitroSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Multifunctional biocompatible chitosan-polypyrrole nanocomposites as novel agents for photoacoustic imaging-guided photothermal ablation of cancer.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
P2860
Q24170384-D06B022C-C626-4F45-92C8-44C98A5F8805Q26740048-AEAB466D-1C30-445B-8BEB-26E3E78D4D4EQ26744566-87C819CE-BF96-43C3-9FF0-0F21D7EC0BBAQ26749391-8EFA1C87-C9AA-4115-8F92-3B8EF71C43C2Q26752676-19831739-668F-43CC-A6F4-6F19396B99C2Q26766305-4D7D9790-80CB-4A60-AFEB-07F01BE63289Q26783705-82585F6C-CDF9-44F5-A23A-7BE9CBFF95D8Q26830028-2281CA1E-74E1-4981-B6D0-4F8157165542Q26862309-314B70B9-D59A-4A53-AE3B-1E42D79CB252Q26995026-61658E33-26A0-412F-9602-DF71E9ABCE9BQ26995835-CDA81EEC-F3DD-4473-9B0C-A72B27CDF53EQ26999288-99EC7B3A-0EE2-441C-8889-FF69BB847647Q27011692-8538C76D-A45F-4393-999D-1FD123A9A116Q27021820-E9BA0015-D22A-4FD6-8B51-661F29B89CBAQ27318502-00BCD8D4-CDAC-4D65-ACD7-A390D3485D31Q28068437-D379AF6B-E236-418D-8475-C853253A1BDAQ28079663-2D1F8382-BBCC-4ABD-B4EC-F66E589B9C12Q28087243-DC984CF1-3235-493F-8EA3-BFE8189D4F6AQ28275835-0998259A-2367-47AF-AC38-9D00088C8B8FQ28394225-DD4549AF-DE94-4220-9BA3-FFF0E867A710Q28397980-351490B8-C67C-4A4D-BDA4-720E45438827Q28473864-0BC551B1-82B4-43E9-9F1C-23CC91D3CE09Q28538039-062353FF-EEC0-4EA3-BDDD-7FB1747409DFQ28538811-B7897B42-887C-4489-87AF-D5F1BC44FA5CQ28541661-D0060391-B6FB-40A9-A9D5-27112CD22F44Q28543911-51F26456-546F-413C-A21F-C8E622F0BEC6Q28544700-E2ADD8B0-6936-4A76-A462-88F58466DD3DQ28546881-6AB6E05B-6613-4ED4-B50D-08B0F26DA9B5Q28550622-CE0F94ED-7DA9-44F3-BD04-A8CCBE15465EQ28649786-E199015F-D354-4CC4-868D-66D722E6B181Q28740385-43760825-35E9-40A7-A248-E04FC88AC89EQ28741592-1B0578DE-2942-4BC7-A479-3E8191156487Q28830511-EFCD8181-DD16-4C99-ABCC-8D41E0CEC31BQ29248618-BA5661DB-14A0-4276-A054-60DCFE8A5C3DQ30300402-6F2C51EE-8A94-4DB2-B4B2-CA5EAAFAB545Q30354565-C03313AC-73D1-44F1-BB7A-D12B87F8B24FQ30360403-9092AA64-B550-49EA-A424-CF2D8752E284Q30361646-C40C9DB6-065A-4A26-9354-108F5AA3F384Q30361758-7BF1A2E3-22F9-4BFB-9EA2-36DE909EBA66Q30366990-2CF88B1E-18F2-46B5-8366-C097A1D33B17
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic nanoparticles for drug delivery in cancer
@ast
Therapeutic nanoparticles for drug delivery in cancer
@en
Therapeutic nanoparticles for drug delivery in cancer
@nl
type
label
Therapeutic nanoparticles for drug delivery in cancer
@ast
Therapeutic nanoparticles for drug delivery in cancer
@en
Therapeutic nanoparticles for drug delivery in cancer
@nl
prefLabel
Therapeutic nanoparticles for drug delivery in cancer
@ast
Therapeutic nanoparticles for drug delivery in cancer
@en
Therapeutic nanoparticles for drug delivery in cancer
@nl
P2093
P3181
P1476
Therapeutic nanoparticles for drug delivery in cancer
@en
P2093
Dong M Shin
Kwangjae Cho
Shuming Nie
Zhuo Georgia Chen
P304
P3181
P356
10.1158/1078-0432.CCR-07-1441
P407
P577
2008-03-01T00:00:00Z